BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2020
View Archived Issues
Microbiome metabolites as immunotherapy adjuvants
Read More
Oxygen therapy harms lungs via lung, gut microbiome
Read More
Positive preclinical data presented for multi-target COVID-19 vaccine
Read More
T-2143, a novel HSP90-PI3K drug conjugate with promising activity in cancer models
Read More
Discovery of a novel FASN inhibitor with promising activity in model of AD
Read More
BrightGene Bio-Medical Technology identifies Gly12Cys mutant GTPase KRAS inhibitors
Read More
New PD-1/PD-L1 and/or PD-L1/CD80 interaction inhibitors patented by Betta Pharmaceuticals
Read More
Jiangsu Vcare Pharmatech discovers JAK inhibitors
Read More
Zhejiang Hisun Pharmaceutical presents new RET inhibitors
Read More
University of Queensland, Preveceutical Medical patent delta- and kappa-opioid receptor antagonists
Read More
Update on development of PGX-YBG inhalable therapeutic for COVID-19
Read More
First patient dosed in phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma
Read More
Topline data presented from phase II study of elobixibat in NAFLD and NASH
Read More
FDA issues complete response letter for filgotinib for the treatment of RA
Read More
Promising interim data presented from phase II study of ERC-1671 in recurrent GBM
Read More
Phase II study of QBECO SSI in colorectal cancer approved in Israel
Read More
Evotec and Novo Nordisk collaborate to develop novel therapies for CKD
Read More
Targeting the adenosine A2A receptor may prevent osteoarthritis progression
Read More